April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Alterations of Limbal Epithelial Stem Cell Markers in Diabetes
Author Affiliations & Notes
  • M. Saghizadeh
    Surgery/Ophthalmology, Cedars-Sinai Medical Center, Los Angeles, California
  • S. Soleymani
    Surgery/Ophthalmology, Cedars-Sinai Medical Center, Los Angeles, California
  • A. Harounian
    Surgery/Ophthalmology, Cedars-Sinai Medical Center, Los Angeles, California
  • S. M. Troyanovsky
    Dermatology, Northwestern University, Chicago, Illinois
  • A. V. Ljubimov
    Surgery/Ophthalmology, Cedars-Sinai Medical Center, Los Angeles, California
  • Footnotes
    Commercial Relationships  M. Saghizadeh, None; S. Soleymani, None; A. Harounian, None; S.M. Troyanovsky, None; A.V. Ljubimov, None.
  • Footnotes
    Support  NIH R01 EY13431, M01 RR00425, Winnick Family Foundation, Eye Defects Research Foundation
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 2954. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Saghizadeh, S. Soleymani, A. Harounian, S. M. Troyanovsky, A. V. Ljubimov; Alterations of Limbal Epithelial Stem Cell Markers in Diabetes. Invest. Ophthalmol. Vis. Sci. 2010;51(13):2954.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : We previously identified several epithelial proteins with altered expression in human diabetic central corneas. Decreased hepatocyte growth factor receptor (c-met) and increased proteinases were implicated in changes of these proteins in diabetes. The purpose was to examine whether limbal stem cell marker expression was altered in diabetes and whether c-met gene therapy could normalize marker expression.

Methods: : Ex vivo

Results: : Staining for ABCG2, N-cadherin, β1 integrin, K15, K17, and K19 was decreased in the diabetic limbus either by intensity or number of positive cells. We provide the first description of corneal expression of K17 that was found in clusters of limbal basal cells but not in the central corneal epithelium. This is the first description of K17 in the cornea. Patterns of tenascin-C, SOD2, ΔN-p63α, and laminin γ3 chain, did not change in diabetic corneas. C-met overexpression was accompanied by increased limbal staining for K17, β1 integrin, and a diabetic marker α3β1 integrin, compared to vector-transduced corneas.

Conclusions: : The data suggest that limbal stem cell compartment is altered in long-term diabetes. Gene therapy, such as with c-met overexpression, could be able to restore normal function to diabetic corneal epithelial stem cells.

Keywords: cornea: epithelium • diabetes • gene transfer/gene therapy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×